trial · primary record
Laquinimod eye drops
Inflammation
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2025-09-30 |
| Primary endpoint | Concentration of Laquinimod in aqueous humor and vitreous samples of human participants |
| Registry ID | NCT06161415 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:06.249Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06161415
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.